NASDAQ: NKTR Shareholder Notice: Lawsuit Alleges Misleading Statements by Nektar Therapeutics
November 14, 2018 at 07:15 AM EST
San Diego, CA -- (SBWIRE) -- 11/14/2018 -- A lawsuit was filed on behalf of investors in Nektar Therapeutics (NASDAQ: NKTR) shares over alleged securities laws violations.
